Articles from KNOREX Ltd.

KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic online advertising products and solutions, today provided a year-end business update highlighting significant commercial progress, including one of the strongest quarters of ad spend transacted through XPO in the Company’s history, as it executes on growth initiatives following its successful NYSE American listing in September. In connection with this update, the Company is also filing a Form 6-K reporting its unaudited interim financial results for the six months ended June 30, 2025.

KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic online advertising products and solutions, today announced it will celebrate the Company’s progress and listing on the New York Stock Exchange by ringing the NYSE Closing Bell at the New York Stock Exchange Building, 11 Wall Street, New York City. KNOREX commenced trading on the NYSE under the ticker symbol “KNRX” on September 29, 2025.

KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic online advertising products and solutions, today announced the launch of a new white-label solutions for a fast-growing live commerce platform that is transforming how creators, sellers, and brands connect online with real-time shoppers across social and streaming channels.

KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic online advertising products and solutions, today announced that its AI-driven cross-channel marketing platform, KNOREX XPOSM, has been successfully deployed by one of Canada’s largest dental care networks to accelerate new patient acquisition across more than 450 clinic locations nationwide.